Option Care Health, Inc. $OPCH Shares Purchased by Livforsakringsbolaget Skandia Omsesidigt

Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 22.9% during the first quarter, HoldingsChannel.com reports. The fund owned 147,400 shares of the company’s stock after buying an additional 27,500 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Option Care Health were worth $4,007,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. V Square Quantitative Management LLC acquired a new stake in Option Care Health in the 4th quarter valued at about $25,000. McIlrath & Eck LLC acquired a new position in shares of Option Care Health during the 2nd quarter worth approximately $37,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health during the 3rd quarter worth approximately $35,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health in the third quarter valued at approximately $38,000. Finally, Employees Retirement System of Texas purchased a new stake in shares of Option Care Health in the fourth quarter valued at approximately $45,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 1.6%

Shares of NASDAQ OPCH opened at $21.35 on Wednesday. The company has a market capitalization of $3.35 billion, a P/E ratio of 16.55, a P/E/G ratio of 1.21 and a beta of 0.65. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The company has a 50 day simple moving average of $21.06 and a 200-day simple moving average of $27.68. Option Care Health, Inc. has a 1 year low of $18.01 and a 1 year high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The firm’s quarterly revenue was up 1.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts predict that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on OPCH. Barrington Research reduced their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. UBS Group restated a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. TD Cowen cut their target price on Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research note on Friday, May 1st. Stephens set a $30.00 price target on Option Care Health in a report on Friday, May 1st. Finally, JPMorgan Chase & Co. lowered their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $30.54.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $21.41 per share, with a total value of $783,820.10. Following the transaction, the director owned 450,000 shares of the company’s stock, valued at $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Timothy P. Sullivan acquired 24,154 shares of Option Care Health stock in a transaction that occurred on Thursday, May 7th. The stock was bought at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the acquisition, the director owned 73,383 shares in the company, valued at $1,518,294.27. This trade represents a 49.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 73,264 shares of company stock worth $1,548,316 over the last quarter. 1.70% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.